# Kaya transformation — final consolidation & handoff (Phase 42)

This closes the safety-led transformation playbook (Phases 0–42) for the KAYA
digital-health platform. It records what was built, the safety posture, and what
a named human release board must still do. **Clinical release remains HOLD.**

## What was delivered

A phase-by-phase set of **domain-pure enforcement modules** (`backend/app/*.py`,
stdlib-only, importable while the app is held), each paired with **negative
tests** (`backend/phaseNN_tests/`), a **doc** (`docs/KAYA_*.md`), and a **local
checkpoint commit** staging only phase-owned files. Governance is fail-closed and
the coding agent is `approval_prohibited` throughout.

- **Foundation & governance (P0–P18):** launch hold (default app returns 503 on
  clinical routes), release board defaulting to HOLD, RACI, append-only evidence,
  four-eyes, separation of duties, redaction, identity/authz/authn, consent,
  onboarding, privileging, operating authority.
- **Clinical safety core (P19–P24):** fail-closed triage input gate, triage
  governance, emergency exclusion, scheduling authority, transactional booking,
  care-episode/queue/handoff state machine.
- **Clinical surfaces (P25–P31):** secure teleconsultation boundary, clinical-note
  integrity, prescribing-safety guardrails, secure messaging, secure file
  handling, AI/LLM egress boundary, connected-device vitals integrity.
- **Platform & infrastructure (P32–P36):** database integrity & migration/backup
  governance, cloud/secrets posture, resilience & DR, supply-chain integrity,
  observability & tamper-evident audit.
- **Release readiness (P37–P41):** web/PWA client safety, payments boundary
  (disabled by default), data-processing governance/ROPA, pre-flight go/no-go,
  and the pilot readiness board.

## Safety posture (held by design)

- Synthetic data only; no real users, PHI, messages, charges, or provisioning.
- Every external provider (video, AI, payments, malware scanner, storage) ships
  **disabled / refusing** with a `BLOCKED_EXTERNAL` real adapter.
- Nothing was pushed, merged, deployed, or migrated against a live system.
- The three pre-existing untracked frontend tests remain preserved and untouched.
- No rule is labeled "clinically validated"; illustrative tables (triage, drug
  safety, vitals ranges, emergency red-flags) are explicitly marked for named
  clinical-owner replacement.

## Current release status — **NOT READY (NO-GO)**

Per the [pilot readiness board](KAYA_PILOT_READINESS.md): **20 external gates, 0
signed READY** (6 BLOCKED_EXTERNAL, 14 OPEN). The [pre-flight gate](KAYA_PREFLIGHT.md)
returns **NO-GO** and clinical release stays **HOLD** until a named human release
board clears the gates with dated evidence and records the six role sign-offs
(clinical_safety, legal, privacy, security, accessibility, operations) through the
governance board with separation of duties.

## What a human must do next

1. Work the [pilot readiness board](KAYA_PILOT_READINESS.md) — assign each of the
   20 gates to its named owner and clear it with evidence.
2. Provision an **isolated, synthetic staging** environment and adopt the
   domain-pure policies at the held endpoints (harness-verified), starting with
   the ORM changes that remove clinical `ondelete=CASCADE`.
3. Sign the DPAs and approve the providers each `BLOCKED_EXTERNAL` adapter needs.
4. Convene the release board; only when pre-flight returns GO does clinical
   release move off HOLD.

## Verification

All backend phase suites pass (`pytest backend/phase*_tests`), the frontend
client-safety and operational-hold suites pass (`vitest`), and `tsc --noEmit` is
clean. Each phase's evidence is in its `docs/KAYA_*.md` and its checkpoint commit;
the canonical per-phase verdicts live in [KAYA_EXECUTION_STATUS.md](KAYA_EXECUTION_STATUS.md).

**Clinical release: HOLD.**
